KNOTUS Co.Ltd (278650) - Total Liabilities

Latest as of September 2025: ₩44.24 Billion KRW ≈ $29.98 Million USD

Based on the latest financial reports, KNOTUS Co.Ltd (278650) has total liabilities worth ₩44.24 Billion KRW (≈ $29.98 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore KNOTUS Co.Ltd cash flow conversion to assess how effectively this company generates cash.

KNOTUS Co.Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how KNOTUS Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of KNOTUS Co.Ltd to evaluate the company's liquid asset resilience ratio.

KNOTUS Co.Ltd Competitors by Total Liabilities

The table below lists competitors of KNOTUS Co.Ltd ranked by their total liabilities.

Company Country Total Liabilities
DCM Corp
KO:024090
Korea ₩31.58 Billion
YEAH1 Group Corp
VN:YEG
Vietnam ₫643.42 Billion
Centrale d'Achat Française pour l'Outre-Mer Société Anonyme
PA:CAFO
France €250.52 Million
Income Opportunity Realty Investors
NYSE MKT:IOR
USA $4.00K
SEOHAN Const. & Eng.co.Ltd
KQ:011370
Korea ₩666.51 Billion
Miko NV
BR:MIKO
Belgium €205.62 Million
Muda Holdings Bhd
KLSE:3883
Malaysia RM1.06 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down KNOTUS Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of KNOTUS Co.Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.29 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.41 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.28 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how KNOTUS Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for KNOTUS Co.Ltd (2016–2024)

The table below shows the annual total liabilities of KNOTUS Co.Ltd from 2016 to 2024.

Year Total Liabilities Change
2024-12-31 ₩56.45 Billion
≈ $38.26 Million
-17.15%
2023-12-31 ₩68.14 Billion
≈ $46.18 Million
-33.14%
2022-12-31 ₩101.91 Billion
≈ $69.06 Million
+239.26%
2021-12-31 ₩30.04 Billion
≈ $20.36 Million
+46.02%
2020-12-31 ₩20.57 Billion
≈ $13.94 Million
+4.60%
2019-12-31 ₩19.67 Billion
≈ $13.33 Million
-14.76%
2018-12-31 ₩23.07 Billion
≈ $15.64 Million
+38.33%
2017-12-31 ₩16.68 Billion
≈ $11.30 Million
+49.28%
2016-12-31 ₩11.17 Billion
≈ $7.57 Million
--

About KNOTUS Co.Ltd

KQ:278650 Korea Biotechnology
Market Cap
$72.81 Million
₩107.45 Billion KRW
Market Cap Rank
#20422 Global
#1188 in Korea
Share Price
₩1272.00
Change (1 day)
-1.93%
52-Week Range
₩1099.00 - ₩1683.00
All Time High
₩36886.01
About

HLB bioStep Co.,Ltd. provides various test services in South Korea. It offers non clinical CRO services for cancer, bone and brain disease, endocrineand metabolic and eye disease, liver and circulatory system disease, dental and gastrointestinal disease, hair growth, kidney and respiratory disease, painmodel, and skin disease. It also offers representative analysis equipment, veterinary drug deve… Read more